Aerami Therapeutics is Drug Delivery in United States that focus on lead asset business. Founded in 2010. They cover business area such as developer, therapy, severe respiratory and chronic disease, imatinib, pulmonary arterial hypertension, its breath actuated inhaler, effectiveness, inhaled drug, well clinical outcome, short treatment time.
2010
( 14 years old in 2024 )
Lead Asset
-
2520 Meridian Parkway
Suite 400
Durham, NC 27713
United States
Private
developertherapysevere respiratory and chronic diseaseimatinibpulmonary arterial hypertensionits breath actuated inhalereffectivenessinhaled drugwell clinical outcomeshort treatment time
* We use standard office opening hours in near Aerami Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aerami Therapeutics is Drug Delivery business from United States that founded in 2010 (14 years old in 2024), Aerami Therapeutics business is focusing on Lead Asset.
Aerami Therapeutics headquarter office and corporate office address is located in 2520 Meridian Parkway Suite 400 Durham, NC 27713 United States.
Aerami Therapeutics was founded in United States.
In 2024, Aerami Therapeutics is currently focus on lead asset sector.
Above is snippet of Google Trends for "lead asset" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aerami Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.